🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
This study will examine the safety, pharmacokinetics, and efficacy of escal...
Status
Terminated
Location
City of Hope National Medical Center ( Site 0004)
Start Date
2019-03-18
Trial ID
NCT03833427
Treatments Being Tested
The primary purpose of the study is to assess the safety, tolerability and ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2007-03-08
Trial ID
NCT00463814
Treatments Being Tested
The primary purpose of this study is to compare the efficacy of AZD6244 (AR...
Status
Completed
Location
Research Site
Start Date
2006-07
Trial ID
NCT00338130
Treatments Being Tested
Study to assess the effect of Selumetinib \[AZD6244; ARRY-142886\] \[Hyd-Su...
Status
Completed
Location
Research Site
Start Date
2014-03
Trial ID
NCT02056392
Treatments Being Tested
This is an open-label, non-randomized, multicenter phase Ib/II study, which...
Status
Completed
Location
National Cheng Kung University Hospital
Start Date
2014-09
Trial ID
NCT02025114
Treatments Being Tested
Study to assess the effect of Rifampicin on the pharmacokinetics of Selumet...
Status
Completed
Location
Research Site
Start Date
2014-02
Trial ID
NCT02046850
Treatments Being Tested
The purpose of this study is to find out how often two investigational drug...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2010-10
Trial ID
NCT01166126
Treatments Being Tested
A Phase 1 Open Label Study to Assess the Safety, Tolerability, Pharmacokine...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-12-16
Trial ID
NCT04590235
Treatments Being Tested
The purpose of this study is to assess the efficacy of selumetinib in combi...
Status
Active Not Recruiting
Location
Research Site
Start Date
2013-09-25
Trial ID
NCT01933932
Treatments Being Tested